Skip to content
Emerging Research

Adalank

Adalank (N-Acetyl Selank Amidate) is an enhanced synthetic derivative of Selank peptide, featuring N-terminal acetylation and C-terminal amidation for superior stability and blood-brain barrier…

Also known as: N-Acetyl Selank Amidate, Enhanced Tuftsin Analog

Typical Dose 200-300mcg
Storage Refrigerate reconstituted; store lyophilized powder away from light
How Often 1x daily (morning)

Overview

Adalank (N-Acetyl Selank Amidate) is an enhanced synthetic derivative of Selank peptide, featuring N-terminal acetylation and C-terminal amidation for superior stability and blood-brain barrier penetration. Developed from the immunomodulatory peptide tuftsin, it's researched for anxiety reduction, cognitive enhancement, neuroprotection, and stress resilience with improved pharmacokinetic properties compared to the parent compound.

Key Benefits

  • Generalized Anxiety Disorder (GAD)
  • Anxiety without Sedation
  • Stress-Related Anxiety

Potent anxiolytic effects, enhanced cognitive function, stress resilience, improved mood and emotional stability, neuroprotection, and immunomodulatory support. Superior bioavailability and extended half-life compared to parent compound Selank.

Mechanism of Action

Adalank crosses the blood-brain barrier via enhanced lipophilicity from N-acetylation and C-terminal amidation. It modulates GABAergic neurotransmission, upregulates BDNF in the hippocampus, influences serotonin metabolism, provides immunomodulatory effects via tuftsin-derived mechanisms, and reduces stress-related neurotransmitters without benzodiazepine dependency.

Research Protocols Injectable

GoalDoseFrequencyRoute
Anxiety reduction200-300mcg1x daily (morning)Subcutaneous
Cognitive enhancement200-500mcg1x dailySubcutaneous
Stress management200-300mcg2x daily (morning, afternoon)Subcutaneous
Initial assessment/trial100-200mcg1x dailySubcutaneous

Research protocols from published literature — not dosing recommendations.

Peptide Interactions

  • Selank — Similar: Adalank is an enhanced derivative of Selank with improved stability and longer half-life
  • Semax — Compatible: Both are Russian nootropic peptides with different mechanisms - Semax for cognitive enhancement, Adalank for anxiety
  • BPC-157 — Compatible: Different mechanisms - Adalank targets neurological/anxiety pathways, BPC-157 focuses on tissue repair
  • Diazepam (Benzodiazepine) — Synergistic: Parent compound Selank enhances benzodiazepine effects while reducing side effects in research studies

Peptide Instructions Injectable

Supplies:

  • Bacteriostatic water (BAC water)
  • Insulin syringes (0.5-1mL)
  • Alcohol swabs
  • Peptide vial
  • Sterile work surface

How to Reconstitute Injectable

  1. 1Clean work area and hands thoroughly with alcohol
  2. 2Calculate required BAC water volume using calculator below
  3. 3Draw calculated BAC water into syringe
  4. 4Inject slowly down vial side (not directly onto powder)
  5. 5Gently swirl until completely dissolved (never shake vigorously)
  6. 6Store reconstituted solution in refrigerator at 2-8°C
  7. 7Use within 14-30 days for optimal potency

What to Expect Injectable

Days 1-3: 40% of users may experience rapid anxiety reduction (based on parent compound research). Week 1-2: Gradual anxiety relief, improved mood, enhanced stress resilience. Week 2-4: Cognitive enhancement, improved focus, BDNF-mediated neuroplasticity. Week 4+: Sustained anxiolytic and cognitive benefits with continued use. Note: N-Acetyl form provides extended effects compared to standard Selank.

Side Effects & Safety

Use sterile injection technique to prevent infection. CRITICAL: This is an experimental peptide with limited direct human research data on N-Acetyl form. Parent compound Selank has extensive Russian clinical research showing high safety profile. No tolerance, dependency, or withdrawal unlike benzodiazepines. Start with lower doses (100-200mcg) to assess individual response. Cycle usage with 1-2 week breaks to prevent potential tolerance. Not FDA-approved; approved for clinical use in Russia since early 2000s. Not recommended during pregnancy or breastfeeding due to lack of safety data. Consult healthcare provider before use, especially with other psychiatric medications.

Use sterile injection technique to prevent infection. CRITICAL: This is an experimental peptide with limited direct human research data on N-Acetyl form. Parent compound Selank has extensive Russian clinical research showing high safety profile. No tolerance, dependency, or withdrawal unlike benzodiazepines. Start with lower doses (100-200mcg) to assess individual response. Cycle usage with 1-2 week breaks to prevent potential tolerance. Not FDA-approved; approved for clinical use in Russia since early 2000s. Not recommended during pregnancy or breastfeeding due to lack of safety data. Consult healthcare provider before use, especially with other psychiatric medications.

Community Insights

Adalank should be stored at Fridge 2-8°C, use within 14-30 days.

Molecular Information

Molecular Weight 792.93 Da (N-Acetyl form)
Length 7
Type Modified heptapeptide (enhanced tuftsin analog)
Sequence Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (N-Acetylated and C-terminal amidated)

References

  1. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats Inozemtsev, A.N., Bokieva, S.B., Karpenko, M.N., et al. · Bulletin of Experimental Biology and Medicine 2019
  2. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats Kasian, A., Kirbaeva, N., Volodina, M., et al. · Behavioural Neurology 2017
  3. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells Filippenkov, I.B., Stavchansky, V.V., Denisova, A.E., et al. · Frontiers in Pharmacology 2017
  4. Optimization of the treatment of anxiety disorders with selank Kolik, L.G., Nadorova, A.V., Kozlovskaya, M.M., et al. · Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova 2015
  5. The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action Sebentsova, E.A., Denisenko, A.V., Levitskaya, N.G., et al. · Immunopharmacology and Immunotoxicology 2013
  6. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders Kolomin, T.A., Agapova, T.Y., Agniullin, Y.V., et al. · Immunopathology, Allergology, Infectology 2013
  7. Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank Levitskaya, N.G., Sebentsova, E.A., Manchenko, D.M., et al. · Regulatory Peptides 2011
  8. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia Uchakina, O.N., Uchakin, P.N., Miasoedov, N.F., et al. · Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova 2008
  9. Selank and BDNF Regulation in Hippocampus (Parent Compound) · 0
  10. Tuftsin Analog Selank and Inflammation-Related Gene Expression (Parent Compound) · 0
  11. Immunomodulatory Effects of Selank in Anxiety Patients (Parent Compound) · 0
  12. Selank for Generalized Anxiety Disorder - Non-inferiority Trial (Parent Compound) · 0

Research reference only. Not medical advice.